Data as of Aug 28
| +0.06 / +0.17%|
The 28 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 36.97, with a high estimate of 46.73 and a low estimate of 22.58. The median estimate represents a +5.43% increase from the last price of 35.06.
The current consensus among 31 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.